Name | Cub Pharmacy #1936/765 |
---|---|
Organization Name | Supervalu Pharmacies Inc |
Location | 417 8th Ave Ne, Brainerd, Minnesota 56401 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (218) 828-0440 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The plaudits have faded for New York Gov. Andrew Cuomo. Once hailed as a paragon of pandemic governing, he's since come under scorching criticism for undercounting the state's covid deaths among nursing home residents by as much as half.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
It's become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in using probiotics proactively in the ICU. A large multicenter clinical trial in Canada is testing whether probiotics would prevent ventilator-associated pneumonia in adult ICU patients.
Unlike the self-repair abilities of our skin, bone and other tissues, which can readily heal and rebuild themselves after injury, evolution has left the mammalian heart with relatively little regenerative capacity.
› Verified 8 days ago
NPI Number | 1285749325 |
Organization Name | SUPERVALU PHARMACIES INC |
Doing Business As | CUB PHARMACY |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 417 8th Ave Ne, Brainerd, MN 56401 |
Phone Number | 218-828-0440 |
News Archive
The plaudits have faded for New York Gov. Andrew Cuomo. Once hailed as a paragon of pandemic governing, he's since come under scorching criticism for undercounting the state's covid deaths among nursing home residents by as much as half.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
It's become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in using probiotics proactively in the ICU. A large multicenter clinical trial in Canada is testing whether probiotics would prevent ventilator-associated pneumonia in adult ICU patients.
Unlike the self-repair abilities of our skin, bone and other tissues, which can readily heal and rebuild themselves after injury, evolution has left the mammalian heart with relatively little regenerative capacity.
› Verified 8 days ago
News Archive
The plaudits have faded for New York Gov. Andrew Cuomo. Once hailed as a paragon of pandemic governing, he's since come under scorching criticism for undercounting the state's covid deaths among nursing home residents by as much as half.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
It's become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in using probiotics proactively in the ICU. A large multicenter clinical trial in Canada is testing whether probiotics would prevent ventilator-associated pneumonia in adult ICU patients.
Unlike the self-repair abilities of our skin, bone and other tissues, which can readily heal and rebuild themselves after injury, evolution has left the mammalian heart with relatively little regenerative capacity.
› Verified 8 days ago
Brainerd Medical Supply Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 206 W Washington St, Brainerd, Minnesota 56401 Phone: (218) 829-2100 | |
North Central Medical Supply Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 314 Charles St, Brainerd, Minnesota 56401 Phone: (218) 825-7331 | |
Walgreens #5635 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 340 W Washington St, Brainerd, Minnesota 56401 Phone: (218) 825-0027 | |
Cub Pharmacy #1936/765 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 417 8th Ave Ne, Brainerd, Minnesota 56401 Phone: (218) 828-0440 | |
Guidepoint Pharmacy #101 Type: Pharmacy Location: 108 S 6th St, Brainerd, Minnesota 56401 Phone: (218) 829-0347 |